Latest Insider Transactions at Avadel Pharmaceuticals PLC (AVDL)
This section provides a real-time view of insider transactions for Avadel Pharmaceuticals PLC (AVDL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AVADEL PHARMACEUTICALS PLC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AVADEL PHARMACEUTICALS PLC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2024
|
Thomas S Mchugh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,300
+2.55%
|
$23,000
$10.44 P/Share
|
|
Dec 11
2024
|
Thomas S Mchugh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+5.52%
|
$50,000
$10.49 P/Share
|
|
Dec 10
2024
|
Geoffrey Michael Glass Director |
BUY
Open market or private purchase
|
Indirect |
20,279
+12.29%
|
$182,511
$9.85 P/Share
|
|
Dec 09
2024
|
Gregory J Divis Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
402
+3.86%
|
$3,618
$9.82 P/Share
|
|
Dec 06
2024
|
Gregory J Divis Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
9,598
+50.0%
|
$86,382
$9.98 P/Share
|
|
Dec 06
2024
|
Linda Palczuk Director |
BUY
Open market or private purchase
|
Direct |
3,000
+4.32%
|
$30,000
$10.19 P/Share
|
|
Jul 30
2024
|
Naseem Amin Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jul 30
2024
|
Eric J Ende Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+5.79%
|
-
|
|
Jul 30
2024
|
Peter J. Thornton Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+10.47%
|
-
|
|
Jul 30
2024
|
Linda Palczuk Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+14.78%
|
-
|
|
Jul 30
2024
|
Geoffrey Michael Glass Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jul 30
2024
|
Mark Anthony Mc Camish Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jan 16
2024
|
Thomas S Mchugh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+2.42%
|
$28,000
$14.5 P/Share
|
|
Dec 28
2023
|
Mark Anthony Mc Camish Director |
SELL
Open market or private sale
|
Indirect |
75,000
-52.81%
|
$1,050,000
$14.53 P/Share
|
|
Aug 14
2023
|
Thomas S Mchugh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+2.48%
|
$28,000
$14.45 P/Share
|
|
Aug 11
2023
|
Mark Anthony Mc Camish Director |
SELL
Open market or private sale
|
Indirect |
28,975
-16.94%
|
$405,650
$14.93 P/Share
|
|
Aug 10
2023
|
Geoffrey Michael Glass Director |
BUY
Open market or private purchase
|
Indirect |
14,000
+19.18%
|
$182,000
$13.4 P/Share
|
|
Aug 10
2023
|
Gregory J Divis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+5.91%
|
$130,000
$13.2 P/Share
|
|
May 18
2023
|
Eric J Ende Director |
BUY
Open market or private purchase
|
Direct |
13,000
+7.19%
|
$169,000
$13.93 P/Share
|
|
May 09
2023
|
Linda Palczuk Director |
BUY
Open market or private purchase
|
Direct |
2,500
+4.55%
|
$35,000
$14.76 P/Share
|
|
Dec 23
2022
|
Linda Palczuk Director |
BUY
Open market or private purchase
|
Direct |
2,000
+3.85%
|
$14,000
$7.2 P/Share
|
|
Nov 29
2022
|
Thomas S Mchugh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+6.14%
|
$35,000
$7.8 P/Share
|
|
Nov 22
2022
|
Eric J Ende Director |
BUY
Open market or private purchase
|
Direct |
20,000
+11.44%
|
$140,000
$7.8 P/Share
|
|
Jun 01
2022
|
Geoffrey Michael Glass Director |
BUY
Open market or private purchase
|
Indirect |
45,000
+50.0%
|
$90,000
$2.14 P/Share
|
|
Jun 01
2022
|
Eric J Ende Director |
BUY
Open market or private purchase
|
Direct |
20,000
+12.91%
|
$40,000
$2.27 P/Share
|
|
May 31
2022
|
Eric J Ende Director |
BUY
Open market or private purchase
|
Direct |
15,000
+11.55%
|
$30,000
$2.16 P/Share
|
|
May 27
2022
|
Peter J. Thornton Director |
BUY
Open market or private purchase
|
Direct |
50,000
+37.58%
|
$50,000
$1.69 P/Share
|
|
May 27
2022
|
Gregory J Divis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+25.11%
|
$100,000
$2.05 P/Share
|
|
May 27
2022
|
Eric J Ende Director |
BUY
Open market or private purchase
|
Direct |
15,000
+13.05%
|
$30,000
$2.45 P/Share
|
|
May 27
2022
|
Thomas S Mchugh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+41.15%
|
$100,000
$2.14 P/Share
|
|
May 27
2022
|
Linda Palczuk Director |
BUY
Open market or private purchase
|
Direct |
10,000
+17.27%
|
$10,000
$1.6 P/Share
|
|
Dec 21
2020
|
Geoffrey Michael Glass Director |
SELL
Bona fide gift
|
Direct |
18,600
-28.31%
|
-
|
|
Jun 25
2018
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
114,034
-10.69%
|
$570,170
$5.99 P/Share
|